首页> 外文OA文献 >PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

【2h】

PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

机译：PND12在美国早期帕金森病的治疗中雷沙吉兰抗罗哌尼洛的延缓释放左旋多巴的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Farkouh R; Wilson MR; Tarrants ML; Castelli-Haley J; Armand C;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials. [J] . Kulisevsky J, Pagonabarraga J Drug safety: An international journal of medical toxicology and drug experience . 2010,第2期

机译：罗匹尼罗与其他多巴胺受体激动剂和左旋多巴在帕金森氏病治疗中的耐受性和安全性：随机对照试验的荟萃分析。
2. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. [J] . Hauser RA, Lew MF, Hurtig HI, Movement disorders . 2009,第4期

机译：早期帕金森病早期与延迟雷沙吉兰治疗的长期结果。
3. Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study [J] . Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2020,第期

机译：睡前左侧左旋多巴作为夜蛾帕金森病的治疗方法：开放标签研究
4. Synthesis Of Levodopa, L-Dopa, Containing Polymers From Reaction With Organic Acid Dichlorides For The Treatment Of Parkinson's Disease [C] . Cara Lea Carraher, Charles E. Carraher Jr, Donna Chamely PMSE Symposia . 2003

机译：Levodopa，L-DOPA的合成，含有与有机酸二氯反应的聚合物治疗帕金森病
5. Objective Vision-Based Assessment of Parkinsonism and Levodopa-Induced Dyskinesia in Persons with Parkinson's Disease. [D] . Li, Michael. 2017

机译：客观的基于视觉的帕金森氏病患者帕金森病和左旋多巴诱发的运动障碍评估。
6. Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial [O] . Cheryl H. Waters, Paul Nausieda, Lyudmila Dzyak, -1

机译：在早期和晚期帕金森氏病中长期使用卡比多巴-左旋多巴（IPX066）进行长期治疗：为期9个月的开放标签扩展试验
7. PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES [O] . Farkouh R, Wilson MR, Tarrants ML, 2009

机译：PND21与美国早期帕金森氏病的其他一线治疗方案相比，雷沙吉兰的成本效益

PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

著录项

引文网络

相似文献

相关主题

期刊订阅